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OBJECTIVE—Reactive oxygen species (ROS) are pro-oxidant
factors in distal neurodegeneration in diabetes. We tested the
hypothesis that sensory neurons exposed to type 1 diabetes
would exhibit enhanced ROS and oxidative stress and deter-
mined whether this stress was associated with abnormal axon
outgrowth.
RESEARCH DESIGN AND METHODS—Lumbar dorsal root
ganglia sensory neurons from normal or 3- to 5-month strepto-
zotocin (STZ)-diabetic rats were cultured with 10 or 25–50
mmol/l glucose. Cell survival and axon outgrowth were assessed.
ROS were analyzed using confocal microscopy. Immunoﬂuores-
cent staining detected expression of manganese superoxide
dismutase (MnSOD) and adducts of 4-hydroxy-2-nonenal (4-
HNE), and MitoFluor Green dye detected mitochondria.
RESULTS—Dorsal root ganglion neurons from normal rats
exposed to 25–50 mmol/l glucose did not exhibit oxidative stress
or cell death. Cultures from diabetic rats exhibited a twofold
(P  0.001) elevation of ROS in axons after 24 h in 25 mmol/l
glucose compared with 10 mmol/l glucose or mannitol. Perikarya
exhibited no change in ROS levels. Axonal outgrowth was
reduced by approximately twofold (P  0.001) in diabetic
cultures compared with control, as was expression of MnSOD.
The antioxidant N-acetyl-cysteine (1 mmol/l) lowered axonal
ROS levels, normalized aberrant axonal structure, and prevented
deﬁcits in axonal outgrowth in diabetic neurons (P  0.05).
CONCLUSIONS—Dorsal root ganglia neurons with a history of
diabetes expressed low MnSOD and high ROS in axons. Oxida-
tive stress was initiated by high glucose concentration in neurons
with an STZ-induced diabetic phenotype. Induction of ROS was
associated with impaired axonal outgrowth and aberrant dystro-
phic structures that may precede or predispose the axon to
degeneration and dissolution in human diabetic neuropathy.
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D
iabetic sensory polyneuropathy in humans and
animal models is associated with a spectrum of
structural changes in peripheral nerves that
includes microangiopathy, axonal degenera-
tion, segmental demyelination, and ultimately loss of both
myelinated and unmyelinated ﬁbers (1,2). It has been
proposed that high glucose concentrations induce toxicity
and cell death in sensory neurons, and this triggers dia-
betic neuropathy through loss of nerve ﬁbers (3). Cultured
embryonic dorsal root ganglion sensory neurons were
exposed to high nonphysiological concentrations of glu-
cose that induced oxidative stress by increasing produc-
tion of reactive oxygen species (ROS), and this was
associated with mitochondrial dysfunction, which resulted
in programmed cell death (4–6).
Morphologic studies have provided a variety of results
in relation to sensory neuron survival in animal models of
diabetes. Long-term studies of 9 months in streptozotocin
(STZ)-diabetic mice revealed a signiﬁcant loss of sensory
neurons (7). In STZ-diabetic rats of up to 12 months’
duration, no signiﬁcant loss of adult lumbar dorsal root
ganglion neurons was observed (8,9). Additionally, in
4-month diabetic BB rats, there was no dorsal root gan-
glion sensory neuron cell death (10); however, by 10
months there was progressive neuronal loss, but promi-
nent only in the small dorsal root ganglion neuron popu-
lation and not involving apoptosis (11). At the same time
there was a signiﬁcant decrease in the numbers of myelin-
ated and unmyelinated ﬁbers, but no evidence of struc-
tural changes in mitochondria in dorsal root ganglion
sensory neurons (11). In STZ-diabetic mice, where loss of
small neurons was also occurring, there was no sign of
activation of the pro-apoptotic markers p38, caspase-3,
and phosphorylated c-jun (12).
Sural nerves from humans with diabetic neuropathy
assessed using quantitative morphometry have signiﬁcant
endoneurial microangiopathy, early structural abnormali-
ties in Schwann cells in myelinated ﬁbers, and degenera-
tion and loss of unmyelinated and myelinated ﬁbers;
however, in intact axons, mitochondria appeared structur-
ally normal (1,13). In addition, studies performed on
postmortem samples from type 2 diabetic patients have
shown the occurrence of dystrophic changes in axon
terminals and within the dorsal root ganglion and auto-
nomic ganglia, but no evidence for signiﬁcant neuronal
cell loss (14,15).
These results show that in vivo in animals and humans,
the impact of diabetes on sensory neuron survival are
discordant with the in vitro studies demonstrating toxic
effects of high glucose concentration leading to apoptosis.
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crepancy was the use of embryonic sensory neurons for in
vitro glucose toxicity studies (3). Cultured embryonic
sensory neurons have phenotypic differences with adult
sensory neurons and are dependent on neurotrophic fac-
tor–derived support for survival (16). Therefore, the aim
of this study was to compare responses of adult dorsal
root ganglion sensory neurons from age-matched control
and 3- to 5-month STZ-diabetic rats exposed to high
glucose concentration. To this end, the effect of high
glucose concentration on oxidative stress and neuronal
survival and axonal morphology was assessed.
RESEARCH DESIGN AND METHODS
Dorsal root ganglion sensory neurons from adult Sprague-Dawley male rats
were isolated and dissociated using a previously described method (17–19).
Rats were age-matched control or 3- to 5-month STZ-diabetic rats that
included cohorts receiving insulin implants (two Linplant implants placed
subcutaneously; LinShin Canada, North Scarborough, ON, Canada). Rats were
made diabetic with a single intraperitoneal injection of 75 mg/kg STZ (Sigma,
St. Louis, MO). End points for body weight, plasma glucose, and hemoglobin
A1C are presented in supplementary Table 1, which is available in an online
appendix at http://diabetes.diabetesjournals.org/cgi/content/full/db09-0034/
DC1. Cells were plated onto poly-DL-ornithine and laminin-coated 12-well
plates (Nunclon Surface, Ottawa, ON, Canada) for the neuronal survival study,
25-mm glass cover slips (German glass no. 1; Electron Microscopy Sciences,
Hatﬁeld, PA) for neurite outgrowth and for immunocytochemistry, and 35-mm
glass-bottom dishes for ROS measurement (catalog no. W20; Bioscience
Tools, San Diego, CA). Neurons were cultured in Ham’s F12 medium (Invitro-
gen, Carlsbad, CA) with 10% fetal bovine serum (FBS; HyClone, Logan, UT) for
long-term cultures (5 days). For short-term cultures, neurons were grown in
deﬁned medium with modiﬁed Bottenstein and Sato’s N2 medium containing:
0.1 mg/ml transferrin, 20 nmol/l progesterone, 100 mol/l putrescine, 30 nmol/l
sodium selenite, and 10 mg/ml BSA (the modiﬁed N2 formulation used did not
include insulin; all obtained from Sigma). Neuronal survival was quantiﬁed by
established methods (20,21). Viable neurons were counted before experimen-
tal treatment and at time points after treatment. Neurons that died in the
intervals between examination points were absent, and the viability of the
remaining neurons was assessed by morphologic criteria. Neurons with
membranes and soma with a smooth round appearance were viable, whereas
neurons with fragmented or distended membranes and vacuolated soma were
nonviable. Four images were collected from each well and from the same
place using marked grids on each well bottom at 1, 4, 7, 21, and 28 days using
a light microscope (phase contrast Nikon Diaphot). Survival was conﬁrmed by
trypan blue exclusion at the last time point. For neurite outgrowth measure-
ments, images of cultures were collected from 10 random ﬁelds from each
well. The longest axon and total number of neurons and number of intersects
of their neurites with a vertical grid were counted using a morphometric
approach and SigmaScan Microsoft software. The total number of intersects
per neuron was taken as the parameter of total axon outgrowth as previously
described (22).
ROS measurement. ROS levels were detected using real-time ﬂuorescence
microscopy on a Carl Zeiss LSM510 inverted confocal microscope using two
dye-based approaches: 1) dihydrorhodamine 123 (DHR123) and 2) 5-(and-6)-
chloromethyl-27-dichlorodihydroﬂuorescein diacetate acetyl ester (CM-
H2DCFDA). Neurons were loaded with 5 mol/l of DHR123 (in 100% EtOH;
Sigma) or 1.2 mol/l CM-H2DCFDA (in 100% anhydrous DMSO; Molecular
Probes) for 30 or 15 min, respectively, at 37°C, and then washed three times
with F-12 and visualized using the argon laser (at 2% power). For DHR123,
excitation (max) was 505 nm and emission (max) 534 nm, and for CM-
H2DCFDA, excitation (max) was 488 nm and emission collected above 510
nm. Images were collected and analyzed as pixel intensity at the level of the
axon or cell body. For axonal signals, all axons in each ﬁeld were assessed,
and, using the Carl Zeiss software package, a line was placed along the length
of the axon and pixel intensity collected per micrometer of axon. Control
experiments were performed to conﬁrm that the DHR123 and CM-H2DCFDA
signals were sensitive to antioxidant (N-acetyl-cysteine) or pro-oxidant (H2O2)
treatment (not shown).
Immunocytochemistry for activated caspase 3,4-hydroxy-2-nonenal,
manganese superoxide dismutase, and phosphorylated neuroﬁlament
H. Dorsal root ganglion neurons were ﬁxed with 4% paraformaldehyde in
phosphate buffer at pH 7.4 for 15 min followed by permeabilizing with 0.3%
Triton X-100 in PBS. Nonspeciﬁc binding was blocked by incubation with
blocking reagent combined with FBS and 1.0 mol/l PBS in proportions of 3:1:1
(catalog no. 1 096 176; Roche, Indianapolis, IN) for1ha troom temperature
and washed with PBS three times. Cells were then incubated with antibodies
to -tubulin isotype III (1:1,000; Sigma, Oakville, ON, Canada), caspase 3
(1:100; Chemicon, Temecula, CA), (E)-4-hydroxy-2-nonenal (4-HNE) adducts
(1:500 anti-4-HNE adducts Pab; Alexis Biochemicals, San Diego, CA), manga-
nese superoxide dismutase (MnSOD; 1:300; StressGen, Ann Arbor, MI), and
phosphorylated neuroﬁlament H (NFH; 1:500 SMI-31; Covance, Berkeley, CA).
For localization of mitochondria, live cultures of dorsal root ganglion neurons
were treated for 15 min with 200 nmol/l MitoFluor Green dye (Molecular
Probes, Eugene, OR) before being ﬁxed for immunostaining for anti-NFH.
Primary antibodies were incubated with slides overnight in a humidiﬁed
chamber followed by ﬂuorescein isothiocyanate– and CY3-conjugated second-
ary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA;
1:250) for3ha troom temperature. Fluorescence signals were examined and
quantiﬁed using a Carl Zeiss Axioscop-2 mot microscope with AxioVision 3
software and equipped with ﬂuorescein isothiocyanate, CY3, 4,6-diamidino-
2-phenylindole ﬁlters, and an AxioCam camera.
Data analysis. Because of the technically difﬁcult nature of the cultures and
the image acquisition, not all images were collected in a blinded fashion,
although a random approach was taken for image capture from each well.
Where appropriate, data were subjected to one-way ANOVA with post hoc
comparison using Tukey’s test (Prism 4; GraphPad Software, San Diego, CA).
In all other cases, standard two-tailed unpaired Student’s t test with Welch’s
correction was performed, which does not assume equal variances, with
signiﬁcance levels of P  0.05, using GraphPad Prism 4.
RESULTS
Initial experiments were designed to test the inﬂuence of
high concentrations of glucose (50 mmol/l) on survival of
sensory neurons in culture, the induction of apoptosis, and
markers of oxidative stress. Sensory neurons from adult
control rats were grown up to 4 weeks in F12 medium with
10% FBS. Healthy neurons were phase bright, and by 1
week, cultures exhibited high numbers of nonneuronal
cells, including Schwann cells, satellite cells, and ﬁbro-
blasts (Fig. 1A and B). High glucose concentration had no
effect on survival of neurons at any time and did not affect
axon outgrowth on day 1 (Fig. 1C and insert). Surviving
dorsal root ganglion neurons did decline over time and had
diminished by 50% by the 28th day; however, there was no
effect of 50 mmol/l glucose on this process. Oxidative
stress and/or induction of apoptosis was assessed by
staining for adducts of 4-HNE and caspase 3 activation.
There was no effect of 50 mmol/l glucose on caspase 3 or
4-HNE adduct expression in neuronal perikarya at 2 or 4
weeks (Fig. 1D and E). However, there was a small
(10–20%), but statistically signiﬁcant, increase of activa-
tion of caspase 3 and 4-HNE adduct expression in the 4- vs.
2-week group of dorsal root ganglion neurons; this effect
was not perturbed by 50 mmol/l glucose.
A second set of experiments tested whether high glu-
cose concentration induced oxidative stress in neuronal
perikarya or axons in cultures of adult sensory neurons
under deﬁned conditions in F12  modiﬁed N2 medium.
To assess oxidative stress, a real-time video microscopy
approach was taken using the ﬂuorescent dye CM-
H2DCFDA. This dye is believed to give a readout of cellular
ROS levels, including peroxynitrite, hydrogen peroxide,
and hydroxyl radicals. Neurons were grown 24 h under
control (10 mmol/l glucose) or high (25 mmol/l) glucose.
Supplementary Fig. 1 shows no effect of 25 mmol/l glucose
on CM-H2DCFDA intensity in neuronal perikarya (supple-
mentary Fig. 1A) or axons (supplementary Fig. 1B). High
glucose concentration did not elevate 4-HNE adducts in
cell bodies (supplementary Fig. 1C) or axons (supplemen-
tary Fig. 1D).
We next determined whether cultured neurons from
STZ-diabetic rats were also refractory to high glucose
concentration. Neurons from age-matched control rats
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low (10 mmol/l) glucose with 10 nmol/l insulin, whereas
neurons from 3- to 4-month STZ-diabetic rats were grown
in F12  modiﬁed N2 medium with 25 mmol/l glucose with
no insulin support (to attempt to mimic diabetes in vivo).
Cell survival of neurons from normal and diabetic rats
over a 4-day period and under deﬁned conditions were
identical. Figure 2 shows the phase contrast images of
sensory neurons from control (Fig. 2A, upper and lower
panels) and STZ-diabetic (Fig. 2B) rats after 4 days in
culture. Diabetic dorsal root ganglion neurons exhibited
abnormal morphologic changes in neurite outgrowth,
which were characterized by less axonal outgrowth (Fig.
2C) and appearance of phase-dark axonal swellings and
beading along neurites (Fig. 2B, lower panel, inset). Sep-
arate cultures from control or STZ-diabetic rats were
grown for 1 day and assessed for level of ROS in cell
bodies and axons using CM-H2DCFDA (Fig. 3A, B, and E)
or DHR123 (Fig. 3C, D, and F) ﬂuorescence imaging. ROS
levels in cell bodies did not differ between control and
diabetic neurons (not shown). Axonal ROS levels in neu-
rons from STZ-diabetic rats showed at least a twofold
elevation compared with control using both dyes (Fig. 3E
and F). Cultures were then grown for 4 days and immu-
nostained for 4-HNE adducts and -tubulin III. Control
cultures exhibited normal axons with very rare instances
of axonal swellings (or varicosities); such swellings were
negative for 4-HNE adduct staining (Fig. 4A, C, and E). In
comparison, cultures from STZ-diabetic rats demonstrated
large numbers of axonal swellings that were characterized
with positive staining for 4-HNE adducts (Fig. 4B, D, and
F). The cell bodies of control and diabetic cultures re-
vealed similar levels of highly positive staining for 4-HNE
adducts.
It was important to determine whether differences in
axonal morphology, ROS levels, and 4-HNE staining be-
tween control and diabetic cultures was controlled by
acute effects in the culture of glucose concentration and/or
insulin. Dorsal root ganglion sensory neurons from STZ-
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FIG. 1. High glucose concentration does not impair adult sensory
neuron survival or induce oxidative stress. A and B: Phase contrast
images of 2-week cultures of adult dorsal root ganglion sensory
neurons grown in deﬁned F12  10% FBS medium with and without 50
mmol/l D-glucose. Note the phase-bright neuronal perikarya and phase-
dark nonneuronal cells (mostly ﬁbroblasts and Schwann cells). C:
Levels of survival of dorsal root ganglion neurons for control (10
mmol/l D-glucose) or 50 mmol/l D-glucose over a 4-week period. Cell
numbers were assessed by morphology under a phase contrast micro-
scope. Values are the means  SE, n  4 replicate cultures. The insert
graph shows no difference in total axonal outgrowth at 24 h. Values are
the means  SE, n  3 replicate cultures. D and E: Levels of 4-HNE
adduct expression or caspase 3 activation in neuronal perikarya in
arbitrary units of ﬂuorescence intensity at 2 and 4 weeks of culture.
Values are the means  SE, n  85–108 neurons. *P < 0.05. glu, glucose;
wks, weeks.
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FIG. 2. Cultured sensory neurons from STZ-diabetic rats exhibit
abnormal morphology and reduced levels of axon outgrowth. A: Upper
and lower panels show phase contrast images of neurons derived from
normal rats at 4 days in culture in deﬁned F12  modiﬁed N2 medium
with 10 nmol/l insulin. B: Upper and lower panels show images of
cultures derived from 3- to 4-month STZ-diabetic rats and grown in
deﬁned media with 25 mmol/l glucose and no insulin. White arrows
show areas of abnormal axonal structure highlighted by swelling and
beading. The insert shows a 3 image exhibiting the phase-dark axonal
swellings. White arrowheads are rare swellings in normal neurons.
Black arrowheads are nonneurons. C: Quantiﬁcation of axonal out-
growth, longest axon, after 1 and 4 days of culture from control or
STZ-diabetic rats. Values are the means  SE, n  58–97 axons. *P <
0.001.
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mmol/l glucose, and 15 mmol/l mannitol ( 10 mmol/l
glucose) in deﬁned F12  modiﬁed N2 medium without
insulin support. ROS level in axons was measured after 1
day of culture (Fig. 5A and B). Quantiﬁcation of ROS
accumulation in axons using CM-H2DCFDA dye showed a
statistical increase in ROS levels after high glucose admin-
istration compared with low glucose concentration (Fig.
5E). High mannitol concentration revealed an intermedi-
ate level of ROS production in axons (Fig. 5E). 4-HNE
adduct accumulation in axons of sensory neurons from
STZ-diabetic rats was measured after 3 days of culture
(Fig. 5C and D). High glucose concentration induced a
signiﬁcant increase in 4-HNE adduct accumulation in
axons compared with those cultured at 10 mmol/l glucose
and mannitol (Fig. 5F). Neurons isolated from STZ-dia-
betic rats treated for the ﬁnal month with insulin that
signiﬁcantly lowered hyperglycemia (supplementary Table
1) did not respond to high glucose with elevated ROS or
4-HNE accumulation in axons (Fig. 5E and F). Studies
were also performed in which STZ-diabetic neurons were
treated with 10 nmol/l insulin in the presence of low or
high glucose concentration, and under such conditions
there was no impact on ROS or 4-HNE levels of the insulin
treatment (data not shown). In addition, an alternative
control was used for mannitol, 15 mmol/l L-glucose, and
results were the same as those seen with mannitol.
Experiments now determined whether oxidative stress
was causally linked to aberrant axonal structure in neu-
rons derived from STZ-diabetic rats. The antioxidant N-
acetyl cysteine (NAC) was tested for its ability to lower
ROS. Cultures from control rats were assessed for ROS
using DHR123 imaging and treated acutely with 1 mmol/l
NAC (Fig. 6). Figure 6A–D shows that NAC rapidly neu-
tralized ROS levels. In a separate experiment, STZ-diabetic
cultures were plated for 1 day in the presence or absence
of 1 mmol/l NAC, and effect on axonal outgrowth was
determined; NAC was clearly able to enhance levels of
total axonal outgrowth (Fig. 6E). Cultures of sensory
neurons from control or STZ-diabetic rats were main-
tained for 3 days (at this time point, diabetic neurons
exhibited 4-HNE staining) (Fig. 5C and D). During the last
24 h of culture, control and STZ-diabetic neurons were
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FIG. 3. Axons of sensory neurons from STZ-diabetic rats exhibit
elevated level of ROS. A and C: Images of ROS levels in axons at 24 h
of adult dorsal root ganglion neuron culture from control rats. Cul-
tures were stained for ROS using CM-H2DCFDA (A) or DHR123 (C)
dye, and cells were grown in deﬁned F12  modiﬁed N2 medium with 10
nmol/l insulin. B and D: Axonal ROS level at 24 h of adult dorsal root
ganglion neuron culture from 3- to 4-month STZ-diabetic rats. Cells
were grown in deﬁned F12  N2 medium with 25 mmol/l glucose and
without insulin. Solid arrows show axons that were quantiﬁed for ROS
level. Open arrow indicates a nonneuronal source of ROS. E and F:
Quantiﬁcation of ROS accumulation in axons of dorsal root ganglion
neurons from control and STZ-diabetic rats is shown in a bar graph
derived from CM-H2DCFDA (E) or DHR123 (F) staining. Values are the
means  SE, n  55–64 axons. *P < 0.001. int., intensity.
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FIG. 4. Axons of neurons of STZ-diabetic rats exhibit swellings that
include adducts of 4-HNE. A, C, and E: Merged immunoﬂuorescent
images stained for 4-HNE (green) and neuron-speciﬁc -tubulin III
(orange) at 4 days of sensory neuron culture from control rats (blue
nuclei were stained with 4,6-diamidino-2-phenylindole). Cells were
grown in F12  modiﬁed N2 deﬁned medium with 10 mmol/l D-glucose
and with 10 nmol/l insulin. B, D, and F: Merged immunoﬂuorescent
images of cultures from STZ-diabetic rats grown in F12  modiﬁed N2
deﬁned medium with 25 mmol/l D-glucose and without insulin. White
arrows show 4-HNE adduct accumulation in axon swellings in STZ-
diabetic neurons. Red arrows show -tubulin III accumulation in rare
swellings without 4-HNE. Yellow arrows indicate nonneurons. Aster-
isks indicates perikarya strongly labeled for 4-HNE. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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all groups of cultures were treated with MitoFluor Green
dye to speciﬁcally stain mitochondria and then ﬁxed and
immunostained for phosphorylated NFH. Figure 7A and B
shows control neurons with normal axonal structure and
uniform axonal localization of mitochondria. Cultures
from STZ-diabetic rats demonstrated abnormal accumula-
tions of mitochondria in axons that colocalized with
phosphorylated NFH staining (Fig. 7C and D). Treatment
with 1 mmol/l NAC signiﬁcantly lowered the number of
axonal swellings in normal and STZ-diabetic cultures (Fig.
7E–G).
Increased ROS under high glucose concentration in
diabetic neurons may reﬂect an impaired capacity to
scavenge free radicals. Therefore, the effect of diabetes
and high glucose on the expression of MnSOD was as-
sessed in isolated mitochondrial preparations from dorsal
root ganglia and in cultured sensory neurons. In Fig. 8, we
present Western blot data demonstrating that MnSOD
expression was reduced by 32% (P  0.005) in mitochon-
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and this was prevented by insulin therapy. Figure 9A and
B shows axonal staining of MnSOD in sensory neurons
from age-matched control rats cultured for 1 day under 10
mmol/l glucose. Results were similar under 25 mmol/l
glucose (images not shown). Neurons from STZ-diabetic
rats cultured under 10 mmol/l glucose for 1 day exhibited
diminished immunostaining for MnSOD (Fig. 9C and D);
however, if cultured in the presence of 25 mmol/l glucose,
then no alteration in MnSOD expression was observed
(Fig. 9E and F). When cultures were maintained for 3 days
in vitro, the ability of 25 mmol/l glucose to maintain or
raise MnSOD expression was signiﬁcantly impaired (Fig.
9G and H).
DISCUSSION
This work demonstrates for the ﬁrst time that high glucose
concentration can induce oxidative stress and axonal
degeneration in adult sensory neurons, but only if these
neurons exhibit an STZ-induced diabetic phenotype. Neu-
rons from normal rats did not exhibit oxidative stress or
cell death under high glucose concentrations. High glu-
cose concentration in neurons from diabetic rats triggered
elevated ROS levels and adducts of 4-HNE speciﬁcally in
axons, with the perikarya being unaffected, and this dis-
tally directed process of oxidative stress resulted in axonal
swelling and axon degeneration. This neurodegenerative
process may have been triggered or exacerbated by im-
paired anti-oxidant defenses, as evidenced by the dimin-
ished expression of MnSOD in axons. However, these
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FIG. 7. Axonal swellings in neurons from STZ-diabetic rats exposed to
high glucose represent accumulations of mitochondria and phosphory-
lated NFH, which are eliminated by antioxidant treatment. In the left
column of immunoﬂuorescent images is MitoFluor Green staining; the
right column exhibits phosphorylated NFH staining (orange). Double-
staining is yellow. Dorsal root ganglion sensory neuron cultures were
derived from age-matched control or 3- to 4-month STZ-diabetic rats
and maintained in deﬁned media for 4 days. STZ-diabetic rat cultures
were grown in 25 mmol/l glucose without insulin. During the ﬁnal 24 h
of culture time, selected control or diabetic cultures were treated with
1 mmol/l NAC. A–F: Control (A and B), STZ-diabetic (C and D), and
STZ-diabetic culture treated for 24 h with 1 mmol/l NAC (E and F).
White arrows indicate areas of colocalization of mitochondria and
phosphorylated NFH. G: Quantiﬁcation of the number of axonal swell-
ings in each treatment group. Values are the means  SE, n  3
replicate cultures. *P < 0.05. (A high-quality digital representation of
this ﬁgure is available in the online issue.)
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FIG. 8. MnSOD expression is reduced in mitochondria of dorsal root
ganglion from STZ-diabetic rats. Dorsal root ganglia from 5-month
control, STZ-diabetic, or insulin-treated diabetic rats were homoge-
nized in mitochondrial isolation buffer containing: 10 mmol/l HEPES
(pH 7.4), 200 mmol/l mannitol, 70 mmol/l sucrose, and 1 mmol/l EGTA.
The dorsal root ganglion homogenate was centrifuged at 800g for 10
min at 4°C followed by centrifugation of the supernatant at 8,000g for
15 min, and the mitochondrial pellet was collected. Mitochondrial
protein preparations (5 g/lane) were resolved on a 12% SDS-PAGE
gel and electroblotted (30V, 16 h) onto nitrocellulose membrane. Blots
were then blocked in 5% nonfat milk containing 0.05% Tween over-
night at 4°C, rinsed in PBS (pH 7.4), and then incubated with rabbit
anti-MnSOD polyclonal antibody (1:2,000 dilution) overnight at 4°C.
Extracellular signal–regulated kinase (1:2,000; Covance) was probed
as a loading control (previously shown not to change in diabetes in
dorsal root ganglia). The blots were rinsed, incubated in Super Signal
West Pico (Pierce Biotechnology, Rockford, IL), and imaged using a
BioRad Fluor-S image analyzer. A and B: Shown are the blots (A) and
chart (B) in which MnSOD signal has been presented relative to total
extracellular signal–regulated kinase levels. Values are the means 
SE, n  6. *P < 0.005 vs. control; **P  0.056 vs. diabetic  insulin
(one-way ANOVA with Tukey’s test). DB, diabetic; Erk and ERK,
extracellular signal–regulated kinase; INS, insulin.
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appearance and content of the axonal swellings closely
resembled dystrophic axons observed in human disease.
Previous studies on cultures of embryonic sensory
neurons have shown that high glucose concentration
triggers oxidative stress, activation of apoptosis, and death
of neurons (4–6). In vitro studies by Russell and col-
leagues (3–5) and Feldman and colleagues (4,6) used
glucose concentrations of 45–50 mmol/l and higher and
showed, using an array of markers of oxidative stress
and apoptosis, that these indexes were enhanced in
cultured embryonic neurons. Instead, we found that sur-
vival of adult sensory neurons from lumbar dorsal root
ganglia of normal or diabetic rats did not change under
high glucose concentrations. This supports previous in
vitro studies on sensory neuron cultures from adult rats
and mice (dissociated and explant), where exposure to a
hyperglycemic environment failed to induce neuronal
death over 1–8 days (23,24). In addition, embryonic sen-
sory neurons given time to mature in vitro for several
weeks also become resistant to the apoptosis-inducing
effects of high glucose concentration (25). Differences
in culture conditions between embryonic and adult
preparations may play a role here, and in particular the
presence of nonneurons in the mature and adult cul-
tures may be protective against hyperglycemia.
However, this glucose insensitivity of adult rat sensory
neurons with respect to cell survival is in good agreement
with in vivo studies on experimentally diabetic rodents
(8–10,12,26). In the STZ and BB rat models of type 1
diabetes, there is no loss of dorsal root ganglion neurons
until 10–12 months of disease, and by this time there is
already extensive distal axon loss (9–11,27). There are
clearly a range of effects of STZ-induced diabetes on
neuronal survival and ﬁber loss in rodent models, depend-
ing on the rodent and/or strain. Clearly, in rat models,
either in vitro or in vivo, neuronal cell loss is not a feature
of the pathogenesis that underlies distal axon loss. It
should be noted that sensory neurons under diabetic
conditions can express markers of apoptosis, e.g., acti-
vated caspase-3, but these indexes are dissociated from
cell death (8). These varied effects of the diabetic state on
neuronal survival in the animal models must be judged
with caution given the ﬁndings that neuronal cell loss in
the human form of the disease is not a major feature of the
pathology. Studies on postmortem lumbar dorsal root
ganglion and sympathetic ganglia derived from type 2
diabetic patients showed ultrastructure of the neuronal
perikarya to be abnormal, with signs of shrinkage and
axonal dystrophy; however, there was no evidence of any
cell loss (14,15). This lack of clear neuronal cell loss
occurred while there was overt distal axonal loss in the
epidermis (28–30) and sural nerve (1,2,31) of type 1 and
type 2 diabetic patients.
The key ﬁnding of the current work is that high glucose
concentration induced oxidative stress in the axons of
sensory neurons isolated from STZ-diabetic rats. This
effect was not caused by osmotic stress, and the presence
or absence of insulin in the culture was irrelevant to the
development of neurodegeneration. The failure of glucose
to enhance such processes in normal neurons clearly
reveals the importance of the “STZ-induced diabetic phe-
notype” of neurons, which we propose provides suscepti-
bility of these neurons to glucose-induced metabolic
stress. Whether such neurons have a metabolic memory
related to previous high glucose concentration–related
stress is impossible to ascertain at this juncture. A more
proﬁtable line of reasoning relates to growth factor star-
vation and alterations in the phenotype of the neuron.
During 3–5 months of STZ-diabetes, the loss of neurotro-
phic support from insulin, glial cell line–derived neurotro-
phic factor, nerve growth factor, and neurotrophin-3 has
been well described, and it is known that these growth
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FIG. 9. Effect of STZ-diabetes on expression of MnSOD in axons of
cultured sensory neurons. Lumbar dorsal root ganglion sensory neu-
rons were isolated from age-matched normal or 5-month STZ-diabetic
rats and cultured with 10 mmol/l (white or black bars) or 25 mmol/l
(gray or red bars) glucose for 1 or 3 days. A–F: Cells were ﬁxed and
immunoﬂuorescently costained for -tubulin III (red; neuron speciﬁc)
(panels A, C, and E show double stain) and MnSOD (green) (panels B,
D, and F show single stain). Charts show 1 day (G) and 3 days (H)o f
MnSOD expression in axons assessed by ﬂuorescence intensity at
100 on a confocal microscope. Values are the means  SE, n  65–94
axons. *P < 0.05 vs. other groups; **P < 0.05. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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sion (32–35). Of particular interest is the ability of insulin
and neurotrophin-3 to correct abnormalities in mitochon-
drial function and calcium homeostasis (17,18,36). There-
fore, in the cultures from diabetic rats studied herein, it is
feasible that the ability to respond to glucose-induced
oxidative stress was impaired as a consequence of subop-
timal mitochondrial function and dyshomeostasis of Ca
2
(37). We believe abnormalities in Ca
2 homeostasis lead-
ing to raised intracellular Ca
2 concentration in neurons in
diabetes is important because this key molecular marker
of neurodegeneration appears more rapidly in the sensory
neurons with the longest axons (36). We know of no other
molecular marker of disease that is speciﬁcally associated
with lumbar dorsal root ganglion sensory neurons with the
longest axons. This abnormal Ca
2 homeostasis could be
attributable to global gene expression changes, including
affects on endoplasmic reticulum resident proteins (e.g.,
SERCA2 [sarcoplasmic reticulum Ca
2-ATPase 2]) (38),
and in addition diabetes may impair expression of pro-
teins associated with antioxidant defenses (e.g., MnSOD
and thioredoxin-interacting protein) (39) and growth fac-
tor receptors (e.g., the p75
NTR receptor) (40). Further-
more, sensitivity of sensory neuron axon outgrowth to
extracellular matrix proteins is known to alter under
stress, e.g., neurons become more sensitive to ﬁbronectin
at the expense of laminin after axonal injury (41). These
changes in cellular phenotype could combine to sensitize
the cell to high glucose concentration and/or changes in
growth factor support.
The axonal swellings observed in diabetic neurons were
comprised of accumulation of phosphorylated NFH and
mitochondria, as seen in dystrophic axonal swellings in
autonomic ganglia and nerve, lumbar dorsal root ganglia,
and epidermal nerve ﬁbers of skin in humans with diabetic
neuropathy (14,15,42). We hypothesize that axonal swell-
ings are sites of mitochondrial and structural protein (e.g.,
NFH) accumulation caused by blockade of their axonal
transport, and the outcome is a dearth of functioning
mitochondria and structural proteins at distal axonal sites.
The absence of structural proteins and ATP-generating
organelles in the distal axon, where high ATP concentra-
tion is required for optimal axonal plasticity in the form of
axon sprouting and regeneration (43), will trigger patho-
logical conditions that lead to an absence of efﬁcient
axonal plasticity. This process may precede or predispose
the axon to degeneration and dissolution, and distal ax-
onal degeneration will follow. A key aspect is that the
neurodegenerative process within the epidermis caused by
the “STZ-induced diabetic state” will not be repaired
through normal regenerative processes because these
repair functions will also be targeted. The diabetic state as
envisaged would include toxic effects of high glucose
concentration in addition to abnormalities in neurotrophic
support.
We believe these degenerative processes proceed more
vigorously in the axon than the perikaryal region of
sensory neurons, and this explains the distal dying back
nature of diabetic sensory polyneuropathy. The axonal
environment during axon sprouting and regeneration
would have a very high ATP demand; in fact, 50% of all
ATP synthesized is required for growth cone motility
during axon sprouting and regeneration (43). Also, ROS
scavenging systems, primarily MnSOD, may not be as
efﬁcient in the axon because of reduced expression. Figure
9 shows that sensory neurons with a STZ-diabetic pheno-
type can mount an MnSOD-based antioxidant defense in
axons in response to high glucose; however, by 3 days in
vitro, the upregulation of MnSOD expression shows signs
of failing and may contribute to enhanced oxidative stress
and associated aberrant axon structure (Fig. 9H). These
events may combine to place an additional load on mito-
chondrial bioenergetics not seen in the perikarya and
sensitize the physiology of the organelle to elevations in
Ca
2 and high glucose concentration.
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